Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,565 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07833332Recruiting
Comparing two procedures for blocked small bowel in Crohn's disease
This study compares two procedures—endoscopic stricturotomy and balloon dilation—to treat a narrowed section (stricture) in the small bowel caused by Crohn's disease. If you have a partial blockage, this trial aims to see which procedure is better at safely opening the bowel.
Guangzhou, GuangdongAges 18–70 - NCT05071131Recruiting
Inulin supplement to improve gut health in kidney disease
This trial studies whether taking inulin—a dietary fiber—can improve gut bacteria and the gut barrier in people with end-stage kidney disease on hemodialysis. It may help reduce gut-related problems that can affect overall health in kidney disease.
BerlinAges 18–75 - NCT03596476Recruiting
Test for reflux causes after proton pump pills fail
This study checks whether a special test of the esophagus after meals can find the exact reason for ongoing reflux symptoms when proton pump pills (PPIs) don’t help. It may help doctors choose the right next treatment for people whose reflux symptoms keep coming back.
Chambray-lès-ToursAges 18 years+ - NCT07817550Enrolling by invitation
Predicting sudden health declines with wearable monitors
This study uses wearable devices and other monitoring tools to see if they can predict when a patient might suddenly get worse within the next 72 hours. By participating, you may help develop early warning systems that could lead to faster medical help.
New York, New YorkAges 18–90 - NCT07819773Recruiting
Device for treating generalized anxiety
This study tests a device that uses magnetic pulses to stimulate the brain, which may help reduce symptoms of generalized anxiety disorder (GAD). The treatment is non-invasive and does not require surgery.
Denver, ColoradoAges 22 years+ - NCT07822529Recruiting
Long-term study of Tremfya for inflammatory bowel disease
This study follows adults with moderate-to-severe Crohn's disease or ulcerative colitis who are starting treatment with guselkumab (Tremfya). It aims to see how well the medication works and how long the effects last over time.
AmiensAges 18 years+ - NCT07821658Recruiting
Lecanemab treatment study for Alzheimer's disease
This study looks at people who are taking or have taken lecanemab (a medication for Alzheimer's disease). It aims to gather more information about the treatment's effects in real-world settings.
Nutley, New JerseyAges Any age - NCT06390189Recruiting
Inflammation resolution in heart and metabolic health
This study examines how your body naturally resolves inflammation, which is important for heart health and conditions like diabetes. It involves blood draws and tests to understand how inflammation works.
AarhusAges 18–75 - NCT04622410Recruiting
Hirschsprung disease patient registry study
This study keeps a research record of people who have Hirschsprung disease and have had surgery. It helps doctors better understand long-term outcomes and care needs for future patients.
LeuvenAges Up to 18 years - NCT07818772Recruiting
Using powerful MRI scans to find markers in motor neuron disease
This study uses a very powerful MRI scanner (7T) to take detailed pictures of the brain and spinal cord in people with motor neuron disease. The goal is to find non-invasive markers that could help diagnose and monitor the disease.
GlasgowAges 18 years+ - NCT07820514Recruiting
Exercise during dialysis for kidney disease
This trial tests whether a structured exercise program during dialysis sessions can help people with chronic kidney disease feel better and improve their health. It is designed for patients who are stable on dialysis and may offer a way to enhance well-being during treatment.
Torre del GrecoAges 18 years+ - NCT07824791Recruiting
Predicting return of Crohn's disease after bowel surgery
This study looks at what happens to people with Crohn's disease after they have surgery to remove a diseased part of their intestine. The goal is to find patterns or signs that might help predict whether the disease will come back, which could help doctors plan better follow-up care.
Guangzhou, GuangdongAges 18–70 - NCT03624374Recruiting
Study of LBSL in people with DARS2 mutations
This trial is a natural history study, meaning it tracks how LBSL (a genetic condition) affects the brain, brainstem, and spinal cord over time. It may help researchers better understand disease patterns and provide information that could support future treatments.
Baltimore, MarylandAges Any age - NCT06491043RecruitingPhase 2
Stem cells for COPD: safety and early effectiveness study
This trial tests whether an infusion of donor stem cells can help people with moderate to severe COPD breathe easier. If you are a current or former smoker aged 40 to 80, your symptoms are stable, and your lung function meets specific targets, you may be able to join.
New Taipei CityAges 40–80 - NCT06207552RecruitingEarly Phase 1
Gene therapy study for children with Fabry disease
This study tests a new gene therapy for children aged 7 to 17 with Fabry disease. The treatment aims to fix the faulty gene that causes the condition, which may help reduce symptoms and prevent organ damage.
ShanghaiAges 7–18 - NCT07814352RecruitingPhase 1
A study of SX-682 with proton radiation therapy for leptomeningeal disease
This trial tests a new drug (SX-682) combined with proton radiation therapy for people whose cancer has spread to the fluid around the brain and spinal cord. The goal is to see if this combination can help control the disease better. You can join if you have melanoma or non-small cell lung cancer that has spread.
Basking Ridge, New JerseyAges 18 years+ - NCT07816835RecruitingPhase 4
Comparing nebulizer vs inhaler for COPD treatment
This study compares two ways of taking COPD maintenance medicines: using a nebulizer vs. using a handheld inhaler. The goal is to see which method works better for people with severe COPD, so researchers can help guide treatment choices.
Saint Charles, MissouriAges 60 years+ - NCT07810296Recruiting
Comparing two tremor medications for Parkinson's disease
This trial compares two commonly used medications, benzhexol and procyclidine, to see which works better for controlling tremor in people with Parkinson's disease. If you have bothersome tremors despite your current levodopa/carbidopa treatment, this study could help find a more effective option.
Lahore, Punjab ProvinceAges 40–70 - NCT07809438RecruitingPhase 2
Comparing PET scans for early Parkinson's detection
This study tests two different PET scan resolutions to see which is better at detecting signs of early Parkinson's. It is for people who are already part of a Parkinson's research study and may help improve early diagnosis.
New Haven, ConnecticutAges 18 years+ - NCT07809932Recruiting
Breast artery calcium scan and heart disease risk in women
This study looks at calcium deposits seen in breast arteries during a routine mammogram to see if they can help predict heart disease risk in women aged 55 to 65. It may help doctors find heart risk earlier without extra tests.
Manhasset, New YorkAges 55–65 - NCT06492187Recruiting
Survey to see if you qualify for infectious disease studies
This trial is a quick survey to see if you might be eligible for future infectious disease studies. It helps researchers understand your health background and find the right study for you.
Brooklyn, New YorkAges 18 years+ - NCT06497387RecruitingEarly Phase 1
PRG-1801 for stubborn lupus kidney and IgG4 disease
This trial tests a new treatment called PRG-1801 for people with lupus nephritis (kidney inflammation from lupus) or IgG4-related disease that has not improved with standard treatments. The treatment uses your own immune cells to target and calm the disease.
Wuhan, HubeiAges 18 years+ - NCT06497361RecruitingEarly Phase 1
PRG-2311 for hard-to-treat lupus nephritis and IgG4 disease
This trial tests a new treatment called PRG-2311 for people with lupus nephritis or IgG4-related disease that has not responded to standard therapies. The treatment uses a type of immune cell therapy (CAR-T) to try to control the disease.
Wuhan, HubeiAges 18 years+ - NCT07808619Recruiting
AI health data study for adults
This study is collecting health data to train an AI system that may help predict or improve health outcomes. By joining, you help develop technology that could benefit patients in the future.
Boulder, ColoradoAges 18 years+
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,565 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.